Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milovan Stojanovic

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Vascular Pharmacology|March 3, 2021
By Discontinuing Beta-Blockers Before an Exercise Test, We may Precipitate a Rebound PhenomenonGoran Koracevic, Sladjana Micic, Milovan Stojanovic
Medicina (Kaunas, Lithuania)|April 28, 2023
A Need for Improvement in the Definition of Resistant Arterial HypertensionGoran Koracevic, Sladjana Micic, Milovan Stojanovic, et al.
Cureus|August 5, 2024
QT Prolongation Preceding Ventricular Fibrillation After Amiodarone Administration: A Case ReportMilovan Stojanovic, Miroslav Nikolic, Ivana Nedeljkovic, et al.
Journal of Human Hypertension|March 3, 2021
Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic riskGoran Koracevic, Milovan Stojanovic, Dragan Lovic, et al.
Current Vascular Pharmacology|January 24, 2022
Rationale for the Concept of Impending Hypertension-Mediated Organ DamageGoran Koracevic, Milovan Stojanovic, Dragan Lovic, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|November 1, 2020
Does HAS-BLED risk score underestimate the risk of bleeding in patients with triple antithrombotic therapy?Milovan Stojanovic, Marina Deljanin-Ilic, Stevan Ilic, et al.
Current Vascular Pharmacology|August 27, 2024
Proposal of a Modified Classification of Hypertensive Crises: Urgency, Impending Emergency, and EmergencyGoran Koracevic, Milovan Stojanovic, Marija Zdravkovic, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|May 8, 2020
Unsolved Problem: (Isolated) Systolic Hypertension with Diastolic Blood Pressure below the Safety MarginGoran Koracevic, Milovan Stojanovic, Tomislav Kostic, et al.
Current Hypertension Reviews|November 4, 2025
Hypertension-Mediated Organ Damages should be Divided into Acute and ChronicGoran Koracevic, Milovan Stojanovic, Marija Zdravkovic, et al.
Expert Review of Cardiovascular Therapy|April 24, 2026
Time for a new category: "acute-on-chronic" hypertensive target organ damageGoran Koraćević, Milovan Stojanovic, Dragan Simic, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Vascular Pharmacology|March 3, 2021
By Discontinuing Beta-Blockers Before an Exercise Test, We may Precipitate a Rebound PhenomenonGoran Koracevic, Sladjana Micic, Milovan Stojanovic
Medicina (Kaunas, Lithuania)|April 28, 2023
A Need for Improvement in the Definition of Resistant Arterial HypertensionGoran Koracevic, Sladjana Micic, Milovan Stojanovic, et al.
Cureus|August 5, 2024
QT Prolongation Preceding Ventricular Fibrillation After Amiodarone Administration: A Case ReportMilovan Stojanovic, Miroslav Nikolic, Ivana Nedeljkovic, et al.
Journal of Human Hypertension|March 3, 2021
Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic riskGoran Koracevic, Milovan Stojanovic, Dragan Lovic, et al.
Current Vascular Pharmacology|January 24, 2022
Rationale for the Concept of Impending Hypertension-Mediated Organ DamageGoran Koracevic, Milovan Stojanovic, Dragan Lovic, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|November 1, 2020
Does HAS-BLED risk score underestimate the risk of bleeding in patients with triple antithrombotic therapy?Milovan Stojanovic, Marina Deljanin-Ilic, Stevan Ilic, et al.
Current Vascular Pharmacology|August 27, 2024
Proposal of a Modified Classification of Hypertensive Crises: Urgency, Impending Emergency, and EmergencyGoran Koracevic, Milovan Stojanovic, Marija Zdravkovic, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|May 8, 2020
Unsolved Problem: (Isolated) Systolic Hypertension with Diastolic Blood Pressure below the Safety MarginGoran Koracevic, Milovan Stojanovic, Tomislav Kostic, et al.
Current Hypertension Reviews|November 4, 2025
Hypertension-Mediated Organ Damages should be Divided into Acute and ChronicGoran Koracevic, Milovan Stojanovic, Marija Zdravkovic, et al.
Expert Review of Cardiovascular Therapy|April 24, 2026
Time for a new category: "acute-on-chronic" hypertensive target organ damageGoran Koraćević, Milovan Stojanovic, Dragan Simic, et al.
Pageof 2